PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance

Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery

(2016) Jeffrey J. Tosoian et al.   EUROPEAN UROLOGY

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature

(2015) Jurgen J. Fütterer et al.   EUROPEAN UROLOGY

PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer

(2014) Prabhakar Mithal et al.   INTERNATIONAL JOURNAL OF UROLOGY

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Genetic markers associated with early cancer-specific mortality following prostatectomy

(2013) Wennuan Liu et al.   CANCER

Lineage Relationship of Gleason Patterns in Gleason Score 7 Prostate Cancer

(2013) I. V. Kovtun et al.   CANCER RESEARCH

Magnetic Resonance Imaging/Ultrasound–Fusion Biopsy Significantly Upgrades Prostate Cancer Versus Systematic 12-core Transrectal Ultrasound Biopsy

(2013) M. Minhaj Siddiqui et al.   EUROPEAN UROLOGY

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance

(2013) Jeffrey J. Tosoian et al.   JOURNAL OF UROLOGY

Genomic Rearrangements of PTEN in Prostate Cancer

(2013) Sopheap Phin et al.   Frontiers in Oncology

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy

(2012) Gaetano Zafarana et al.   CANCER

Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4

(2012) A. G. Sowalsky et al.   CANCER RESEARCH

Prostate Cancer Mortality following Active Surveillance versus Immediate Radical Prostatectomy

(2012) J. Xia et al.   CLINICAL CANCER RESEARCH

Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades

(2012) Jonathan I. Epstein et al.   EUROPEAN UROLOGY

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade

(2012) Maisa Yoshimoto et al.   MODERN PATHOLOGY

Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis

(2012) Viacheslav Iremashvili et al.   PROSTATE

Low Prostate-specific Antigen and No Gleason Score Upgrade Despite More Extensive Cancer During Active Surveillance Predicts Insignificant Prostate Cancer at Radical Prostatectomy

(2012) Jeong S. Han et al.   UROLOGY

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

(2011) T. L. Lotan et al.   CLINICAL CANCER RESEARCH

PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications

(2011) Maisa Yoshimoto et al.   GENES CHROMOSOMES & CANCER

Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range

(2011) K. Nagao et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance

(2011) Sima P. Porten et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular classification of prostate cancer using curated expression signatures

(2011) E. K. Markert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas

(2010) Silvia de Muga et al.   MODERN PATHOLOGY

8q24 allelic imbalance and MYC gene copy number in primary prostate cancer

(2010) H Chen et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Chromosome 8p Deletions and 8q Gains are Associated with Tumor Progression and Poor Prognosis in Prostate Cancer

(2009) A. T. El Gammal et al.   CLINICAL CANCER RESEARCH

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

(2009) Bo Han et al.   MODERN PATHOLOGY